175 related articles for article (PubMed ID: 36203138)
21. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
[TBL] [Abstract][Full Text] [Related]
22. Methylated
Zhao G; Liu X; Liu Y; Ma Y; Yang J; Li H; Xiong S; Fei S; Zheng M; Zhao X
J Cancer; 2021; 12(9):2665-2672. PubMed ID: 33854626
[No Abstract] [Full Text] [Related]
23. Analysis of
Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M
J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988
[TBL] [Abstract][Full Text] [Related]
24. Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Li R; Qu B; Wan K; Lu C; Li T; Zhou F; Lin J
FEBS Open Bio; 2021 Jul; 11(7):1941-1952. PubMed ID: 33955718
[TBL] [Abstract][Full Text] [Related]
25. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
[No Abstract] [Full Text] [Related]
26. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
27. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
[TBL] [Abstract][Full Text] [Related]
28. Performance Comparison Between Plasma and Stool Methylated
Liu Y; Zhao G; Miao J; Li H; Ma Y; Liu X; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Front Genet; 2020; 11():324. PubMed ID: 32373158
[TBL] [Abstract][Full Text] [Related]
29. Systematic review of blood diagnostic markers in colorectal cancer.
Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
[TBL] [Abstract][Full Text] [Related]
31. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis.
Wang L; Liu Y; Zhang D; Xiong X; Hao T; Zhong L; Zhao Y
BMC Gastroenterol; 2022 Jun; 22(1):314. PubMed ID: 35754025
[TBL] [Abstract][Full Text] [Related]
33. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
35. Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.
Liu YM; Peng L; Chen C; Zhou P; Cheng B; Luo Y; Zhou MF; Xuan SX; Lin JD; Yin WG
Ann Med; 2023; 55(2):2261111. PubMed ID: 37783044
[TBL] [Abstract][Full Text] [Related]
36. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.
Shen Y; Wang D; Yuan T; Fang H; Zhu C; Qin J; Xu X; Zhang C; Liu J; Zhang Y; Wen Z; Tang J; Wang Z
Clin Epigenetics; 2023 Feb; 15(1):26. PubMed ID: 36803423
[TBL] [Abstract][Full Text] [Related]
37. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
38. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
39. Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation.
Liu C; Xu L; Li W; Jie M; Xue W; Yu W
Biomed Res Int; 2021; 2021():1479748. PubMed ID: 34621892
[TBL] [Abstract][Full Text] [Related]
40. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
